ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

INBX Inhibrx Inc

34.15
0.14 (0.41%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Inhibrx Inc INBX NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.14 0.41% 34.15 16:22:21
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
34.35 33.87 34.45 34.15 34.01
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
11/3/202415:26EDGAR2Form 144 - Report of proposed sale of securities
08/3/202415:08EDGAR2Form 144 - Report of proposed sale of securities
08/3/202414:28EDGAR2Form 144 - Report of proposed sale of securities
06/3/202415:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202413:58EDGAR2Form 144 - Report of proposed sale of securities
04/3/202417:26EDGAR2Form 144 - Report of proposed sale of securities
29/2/202416:26EDGAR2Form PREM14A - Preliminary proxy statements relating to..
28/2/202408:15PRNUSInhibrx Reports Fourth Quarter and Fiscal Year 2023..
28/2/202408:12EDGAR2Form 8-K - Current report
28/2/202408:10EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
14/2/202415:12EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
06/2/202415:30EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
26/1/202411:12PRNUSKuehn Law Encourages DOC, BATL, KAMN, and INBX Investors to..
23/1/202416:25EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
23/1/202405:38EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
23/1/202405:35EDGAR2Form 8-K - Current report
23/1/202405:05DJNSanofi to Buy Assets From Inhibrx in Deal Valued at Up to..
23/1/202404:40IHMARKETNEWSWall Street Highlights: Vroom Shuts Down Online Car Sales,..
23/1/202400:00PRNUSInhibrx Announces Sale of INBRX-101 to Sanofi for an..
09/11/202315:03EDGAR2Form 8-K - Current report
09/11/202315:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202315:00PRNUSInhibrx Reports Third Quarter 2023 Financial Results and..
02/11/202308:16EDGAR2Form 8-K - Current report
02/11/202308:15PRNUSInhibrx Announces Preliminary Data from the Phase 1 Trial of..
18/10/202315:00PRNUSInhibrx Announces Participation in Upcoming Scientific..
19/9/202315:03EDGAR2Form 8-K - Current report
19/9/202315:00PRNUSInhibrx Retains Rights to INBRX-101 for the Treatment of..
31/8/202315:06EDGAR2Form D - Notice of Exempt Offering of Securities
29/8/202308:03EDGAR2Form 8-K - Current report
29/8/202308:00PRNUSInhibrx Announces $200 Million Private Placement Financing
07/8/202315:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/8/202315:00PRNUSInhibrx Reports Second Quarter 2023 Financial Results and..
30/5/202308:46DJNInhibrx Granted FDA Fast Track Designation for INBRX-101
30/5/202308:00PRNUSInhibrx Granted Fast Track Designation for INBRX-101 for the..
08/5/202315:05PRNUSInhibrx Reports First Quarter 2023 Financial Results and..

Su Consulta Reciente

Delayed Upgrade Clock